The Research Cross-Journal Editorial Team supports the Nature-branded research journals, with a focus on handling primary research manuscripts.

Head of Team | Prateek Dongare, PhD, Springer Nature, Berlin, Germany,
Prateek has a background in chemistry & material science, specializing in catalysis and solar energy research. He joined Communications Chemistry in 2018 as an Associate Editor and later transitioned to Nature Communications in 2019, taking on roles as Team Manager and Chief Editor for energy materials in 2023. During his tenure, Prateek spearheaded a team handling submissions on energy materials. Beyond team management, Prateek handled submissions in all areas of the team’s remit such as materials for energy, photo and electrocatalysis, electrochemical energy storage, and energy harvesting.
Prateek left Nature Communications in December 2023 to establish and lead the Research Cross-Journal Editorial Team. Prateek’s academic background includes a PhD degree from Memorial University, Canada, followed by post-doctoral positions at Uppsala University in Sweden and The University of North Carolina-Chapel Hill, USA. 

Senior Technical Editor: Georgia Tsoukala, PhD, Springer Nature, London, UK
Georgia earned her Ph.D. in Pharmaceutical Chemistry from The School of Pharmacy, University of London (now UCL School of Pharmacy), where her research focused on designing and synthesizing carbohydrate-based compounds with potential anticancer properties. Following a brief period as a medicinal chemist at the drug discovery and development company Evotec (UK), she joined the Nature Publishing Group. In her role as a Technical Editor, Georgia contributed to semantic enrichment projects and the creation of chemical compound information pages. Her responsibilities have since expanded to include assisting editors in the preparation of figures containing chemical structures.

Senior Editor: Michelle Korda, PhD, Springer Nature, London, UK
Michelle managed advanced therapy clinical trials at University College London (UCL) and ran a stratified medicine consortium and clinical trial for the treatment of rheumatoid arthritis at Queen Mary University of London. Her expertise encompasses advanced-therapy clinical trials and in vivo and in vitro models for bone-defect healing. Michelle obtained a PhD in biomedical engineering from UCL in 2007, focusing on stem cells’ regenerative capabilities around revision hip implants. Michelle started her editorial career at Nature Biomedical Engineering as part of its launching team in May 2016. In her role, she managed a broad spectrum of submissions, with a focus on medical devices and tissue engineering. Michelle brings a wealth of experience and an understanding of cutting-edge biomedical research to her role. Michelle joined the Research Cross-Journal Editorial team in January 2024.